Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Visible light Photocatalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112574056B reveals a green photocatalytic route for alpha,alpha-difluoro-gamma-hydroxyacetamide derivatives, offering cost reduction and scalable manufacturing for pharma.
Patent CN110483346B reveals a visible-light photocatalytic method for synthesizing sulfonyl-substituted alpha-cyclopropyl styrenes, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN114853707A details a novel photocatalytic route for difluoromethylated 2,3-dihydrobenzopyran-4-ones, offering safer reagents and commercial scalability for pharmaceutical intermediates.
Novel blue-light mediated synthesis of 3-thioether quinoxalinones offers high purity and scalable routes for complex pharmaceutical intermediates manufacturing.
Patent CN106317065B enables green photocatalytic synthesis. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing globally.
Patent CN116396315A details a mild visible-light method for 1,4-dihydronaphthalenes, offering cost-effective routes for pharmaceutical intermediates.
Novel photocatalytic method for thietane indoline heterocycles. High yield, mild conditions, scalable for pharmaceutical intermediates manufacturing.
Patent CN112375102B details a green visible-light catalyzed method for synthesizing phosphonylated imidazopyridines, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN111689912A reveals a metal-free g-C3N4 photocatalytic route for quinoxalinones, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN115925609A details a green FeCl2-catalyzed route to 3-alkenyl oxindoles. This method offers significant cost reduction and supply chain reliability for API manufacturing.
Patent CN109503472B details a mild, two-step photocatalytic route for heterocyclic sulfones. Achieve high purity and cost reduction in fine chemical manufacturing with scalable methods.
Novel Pd-catalyzed visible light method for SuFEx warheads. High purity pharmaceutical intermediates with scalable green chemistry processes.
Patent CN113501766B details a novel asymmetric synthesis route for difluoroalkyl cyclopentenones using visible light catalysis, offering high purity and cost reduction in pharmaceutical manufacturing.
Patent CN111205185B details a green Mn-catalyzed synthesis of beta-trifluoromethyl alcohols using visible light, offering cost-effective solutions for pharmaceutical intermediates.
Novel visible-light method for amino acids. Reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN115611756A reveals a visible-light mediated synthesis for alpha-substituted glycine derivatives, offering a green route for high-purity agrochemical intermediates with reduced metal contamination.
Patent CN106977470B enables green synthesis of 2-iminothiazoline derivatives. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN117720479A reveals visible light catalysis for benzothiazole. Offers green manufacturing and cost reduction for pharmaceutical intermediates supply chains.
Patent CN121517275A reveals a visible light photocatalytic method for polyfluoroalkyl aromatic hydrocarbons, offering cost reduction and supply chain reliability for fine chemical manufacturing.
Novel visible-light method for beta-aminocarbonyls using oxalyl oxime esters. High yield, mild conditions. Cost-effective pharma intermediate manufacturing solution.